Anti-CFHR3 antibody [EPR25759-72]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal Complement factor H-related protein 3 antibody. Suitable for WB, ICC/IF, IP and reacts with Human, Recombinant fragment - Human samples.
View Alternative Names
CFHL3, FHR3, CFHR3, Complement factor H-related protein 3, FHR-3, DOWN16, H factor-like protein 3
- ICC
Supplier Data
Immunocytochemistry - Anti-CFHR3 antibody [EPR25759-72] (AB302792)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized Raji (human Burkitt's lymphoma B lymphocyte) cells labelling CFHR3 with ab302792 at 1/50 (10.74 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2 ug/ml dilution (Green). Confocal image showing cytoplasmic staining in Raji cell line and weak staining in HepG2 cell line.Low expression : HepG2 is observed. ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5 ug/ml dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2 ug/ml dilution.
- WB
Lab
Western blot - Anti-CFHR3 antibody [EPR25759-72] (AB302792)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The doublet bands represent two isoforms of CFHR3 (PMID : 8428964).
Low expression : HepG2 (Human Protein Atlas)
This blot was developed using a high sensitivity ECL substrate.
All lanes:
Western blot - Anti-CFHR3 antibody [EPR25759-72] (ab302792) at 1/1000 dilution
Lane 1:
Daudi (human Burkitt's lymphoma lymphoblast), whole cell lysate at 20 µg
Lane 2:
Raji (human Burkitt's lymphoma B lymphocyte), whole cell lysate at 20 µg
Lane 3:
HepG2 (human hepatocellular carcinoma epithelial cell), whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 37 kDa
Observed band size: 35 kDa,40 kDa
false
Exposure time: 37s
- WB
Lab
Western blot - Anti-CFHR3 antibody [EPR25759-72] (AB302792)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
CFHR3 is a glycoprotein of approximately 50 kDa and detected as 37/35 kDa bands after Protein Deglycosylation Mix II treatment.(PMID : 23830046)
All lanes:
Western blot - Anti-CFHR3 antibody [EPR25759-72] (ab302792) at 1/1000 dilution
Lane 1:
Untreated human plasma at 15 µg
Lane 2:
Human plasma treated with Protein Deglycosylation Mix II at 15 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 37 kDa
Observed band size: 50 kDa,37 kDa,35 kDa
false
Exposure time: 103s
- WB
Lab
Western blot - Anti-CFHR3 antibody [EPR25759-72] (AB302792)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
This antibody does not cross-react with human CFHR4.
Both recombinant proteins were made in-house and expressed from a mammalian expression system.
All lanes:
Western blot - Anti-CFHR3 antibody [EPR25759-72] (ab302792) at 1/1000 dilution
Lane 1:
His-tagged human CFHR3 recombinant protein at 10 ng
Lane 2:
His-tagged human CFHR4 recombinant protein at 10 ng
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 37 kDa
Observed band size: 45-50 kDa
false
Exposure time: 10s
Related conjugates and formulations (1)
-
Anti-CFHR3 antibody [EPR25759-72] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CFHR3 acts as an antagonist to complement factor H by competing for binding sites on target surfaces and complement components. It does not function as a standalone protein but interacts closely within a family that includes CFH and other complement factor H-related proteins. CFHR3 can potentially form complexes with similar proteins to help finely tune the activity of the complement system to prevent excessive immune response.
Pathways
CFHR3 is a part of the complement cascade system specifically the alternative pathway. It contributes to the negative regulation of this pathway which is important for preventing overactivation that could harm host tissues. The protein influences the binding of complement proteins like C3b an essential component in the complement cascade and interacts with other factor H-related proteins such as CFHR1 to modulate pathway activities.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com